Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cancer Survival Analysis01:21

Cancer Survival Analysis

342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Cancer Vaccines01:30

Cancer Vaccines

352
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
352
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Frontiers in molecular biosciences·2026
Same author

Characteristics and Clinical Outcomes of Lyme Arthritis: A Retrospective Study.

Open forum infectious diseases·2026
Same author

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Medical sciences (Basel, Switzerland)·2026
Same author

Early Experience With Beta-Lactam Therapeutic Drug Monitoring in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program.

Open forum infectious diseases·2026
Same author

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Medicina (Kaunas, Lithuania)·2026
Same author

Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC.

Medical sciences (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 23, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.7K

Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations.

Walid Shalata1,2, Zoe Gabrielle Attal3, Adam Solomon3

  • 1The Legacy Heritage Cancer Center and Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.

International Journal of Molecular Sciences
|June 19, 2024
PubMed
Summary
This summary is machine-generated.

Melanoma treatments are advancing with immunotherapy and targeted therapies improving outcomes for all stages. Novel approaches show promise, especially for brain metastasis, offering new hope for patients.

Keywords:
BRAFbrain metastasisimmunotherapymelanomametastaticskin cancertyrosine kinase inhibitors

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.4K

Related Experiment Videos

Last Updated: Jun 23, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.4K

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is a prevalent and aggressive skin cancer with a high risk of metastasis.
  • Traditional treatments face challenges due to melanoma's complex pathogenesis.
  • Recent understanding of tumor biology drives new therapeutic strategies.

Purpose of the Study:

  • To synthesize current knowledge on melanoma staging and prognostic factors.
  • To highlight emerging therapeutic modalities, focusing on neoadjuvant and adjuvant treatments.
  • To review advancements in targeted therapies and immunotherapy for melanoma.

Main Methods:

  • Comprehensive literature review of recent advancements in melanoma treatment.
  • Analysis of clinical outcomes across different disease stages (neoadjuvant, adjuvant, metastatic).
  • Focus on novel therapeutic strategies including immunotherapy and targeted agents.

Main Results:

  • Immunotherapy and tyrosine kinase inhibitors show significant potential to improve outcomes.
  • Groundbreaking progress has been made in treating melanoma brain metastasis.
  • Neoadjuvant and adjuvant strategies, including immunotherapy, are demonstrating efficacy.

Conclusions:

  • Targeted therapies and immunotherapy represent a paradigm shift in melanoma management.
  • Emerging treatments offer improved prognosis, particularly for advanced and metastatic disease.
  • Ongoing trials continue to explore novel therapeutic avenues for melanoma.